Daniel Bock, Germany



Dr. Daniel Bock has been in pharmaceutical R&D with a focus on inflammatory diseases for 20 years. His expertise spans from early drug discovery to clinical proof of concept and beyond. He held R&D positions at Novartis and Revotar Biopharmaceuticals before working as an independent consultant, advisor and interim manager.